The conclusion of a groundbreaking collaborative effort to advance research on visceral leishmaniasis & post-kala-azar dermal leishmaniasis.

in June 2024 the University of York research team conducted training and mass sample analysis at KEMRI and Makerere University (MU), Uganda.

For the first time in five years, members of the PREV_PKDL consortia were able to meet in person for the 6th annual meeting on the 3rd of Ju

The PREV_PKDL 5th annual meeting was held online on 15-17 May to present and discuss project advancements and upcoming activities....

Makerere University, partner in the EVI-led PREV_PKDL project, is participating in the WorldLeish7 congress taking place from August 1st...

The multidimensional, multiparameter phenotyping study (ImmStat@Cure, NCT04342715) within the PREV_PKDL project has kicked-off in April...

The PREV_PKDL 4th annual meeting was held online on 28 April 2022 to present and discuss project advancements and upcoming activities....

Knowledge sharing and capacity building are key to advance scientific research and innovation. One of the main objectives of the...

The Tenth EDCTP Forum biannually provides an international platform for the presentation and discussion of cutting-edge research...

The PREV_PKDL third annual meeting was successfully held via a three-hour teleconference on 27 April 2021.

Knowledge sharing and capacity building are key to advance scientific research and innovation. One of the main objectives of the...

New article was published by Prof. Paul Kaye in PLOS Neglected Tropical Diseases.

The article titled "Expanding research capacity into neglected tropical diseases" by Prof Dr Paul Kaye was published on July 8th on ...

Prof Kaye, partner in the PREV_PKDL project, explores how flow cytometry can help to diagnose and develop a vaccine against leishmaniasis.

One of the aims of PREV_PKDL project is to establish New Flow Cytometry Centre of Excellence for East Africa. On 13 of May Beckman...